Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Shares, no par value per share
-
Shares outstanding
-
47,601,550
-
Total 13F shares
-
36,830,236
-
Share change
-
+292,205
-
Total reported value
-
$522,912,278
-
Price per share
-
$14.20
-
Number of holders
-
55
-
Value change
-
+$10,378,102
-
Number of buys
-
27
-
Number of sells
-
38
Institutional Holders of ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) as of Q4 2021
As of 31 Dec 2021,
ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) was held by
55 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,830,236 shares.
The largest 10 holders included
Bellevue Group AG, Soleus Capital Management, L.P., JANUS HENDERSON GROUP PLC, EVENTIDE ASSET MANAGEMENT, LLC, Blackstone Inc, BVF INC/IL, RTW INVESTMENTS, LP, Avidity Partners Management LP, ADAGE CAPITAL PARTNERS GP, L.L.C., and Logos Global Management LP.
This page lists
56
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.